wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients
Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare weekly-XELIRI(wXELIRI) regimen versus FOLFIRI regimen in
the treatment of advanced colorectal cancer patients. The hypothesis is the efficacy of
wXELIRI is not less than FOLFIRI with tolerable toxicity.